Sgs Quay Pharmaceuticals Limited
Manufacture of pharmaceutical preparations · Ellesmere Port
ActiveUnited KingdomIncorporated 2001Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2022-12-31
IXBRL · 402 source facts · 31 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 402 source facts · 31 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 297
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0019_04144769_20221231
- Source archive
- Accounts_Monthly_Data-July2023.zip
Accounts to 2021-12-31
IXBRL · 353 source facts · 29 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 353 source facts · 29 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 228
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0107_04144769_20211231
- Source archive
- Accounts_Monthly_Data-June2022.zip
Accounts to 2021-05-31
IXBRL · 352 source facts · 29 selected values
Not assessedlegacy record
Accounts to 2021-05-31
IXBRL · 352 source facts · 29 selected values
Not assessed
legacy record
- Reporting period
- 2020-06-01 to 2021-05-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 232
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0100_04144769_20210531
- Source archive
- Accounts_Monthly_Data-January2022.zip
Accounts to 2020-05-31
IXBRL · 456 source facts · 37 selected values
Not assessedlegacy record
Accounts to 2020-05-31
IXBRL · 456 source facts · 37 selected values
Not assessed
legacy record
- Reporting period
- 2019-06-01 to 2020-05-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 347
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0090_04144769_20200531
- Source archive
- Accounts_Monthly_Data-May2021.zip
Accounts to 2013-05-31
IXBRL · 74 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2013-05-31
IXBRL · 74 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2012-06-01 to 2013-05-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 58
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0004_04144769_20130531
- Source archive
- Accounts_Monthly_Data-March2014.zip
Registered details
04144769- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2001-01-19
- Jurisdiction
- —
- Registered office
- ROSSMORE BUSINESS PARK, INWARD WAY, ELLESMERE PORT, CHESHIRE, CH65 3EN, ENGLAND
Classification
2 SIC codes2120074909
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsLiverpool John Moores University and Quay Pharmaceuticals LimitedInnovate UK · Knowledge Transfer Partnership · 2021-05-01 – 2023-04-30 · with 1 other participant
Liverpool John Moores University and Quay Pharmaceuticals Limited
Innovate UK · Knowledge Transfer Partnership · 2021-05-01 – 2023-04-30 · with 1 other participant
Liverpool John Moores Universitylead£121,527
SGS Quay Pharmaceuticals Limited—
The University of Manchester and SGS Quay Pharmaceuticals LimitedInnovate UK · Knowledge Transfer Partnership · 2021-01-01 – 2024-03-31 · with 1 other participant
The University of Manchester and SGS Quay Pharmaceuticals Limited
Innovate UK · Knowledge Transfer Partnership · 2021-01-01 – 2024-03-31 · with 1 other participant
SGS Quay Pharmaceuticals Limited—
Development of a Scalable Manufacturing Process for a Novel Oral Infliximab Product using the Soteria TechnologyInnovate UK · Collaborative R&D · 2018-10-01 – 2021-09-30 · with 3 other participants£97,168awarded
Development of a Scalable Manufacturing Process for a Novel Oral Infliximab Product using the Soteria Technology
Innovate UK · Collaborative R&D · 2018-10-01 – 2021-09-30 · with 3 other participants
£97,168
awarded
Quay Pharmaceuticals Limited£97,168
ACT - Development of a novel AhR-based Cancer TreatmentLead
Innovate UK · EU-Funded · 2015-10-01 – 2019-03-31
£221,093
awarded
Glyndwr University And Quay Pharmaceuticals LimitedInnovate UK · Knowledge Transfer Partnership · 2012-10-01 – 2015-07-31 · with 1 other participant
Glyndwr University And Quay Pharmaceuticals Limited
Innovate UK · Knowledge Transfer Partnership · 2012-10-01 – 2015-07-31 · with 1 other participant
Glyndwr Universitylead£80,700
SGS Quay Pharmaceuticals Limited—